Nouvelle déclaration d'incident
No de la demande: 2020-1492
Numéro de référence du titulaire d'homologation: 2020-US-002267
Nom du titulaire (nom légal complet, aucune abbréviation): Wellmark International
Adresse: 100 Stone Road West, Suite 111
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G5L3
Incident chez un animal domestique
Pays: UNITED STATES
État: GEORGIA
ARLA No d'homologation 31446 ARLA No de la demande d'homologation EPA No d'homologation. 2596-83-89459
Nom du produit: Zodiac Breakaway Flea and Tick Collar for Cats
Autre (préciser)
CollarOui
Autres unités: collar
Site: Animal / Usage sur un animal domestique
Non
Propriétaire de l'animal
Cat / Chat
Domestic Shorthair Cat
1
Homme
5
4.99
kg
Cutanée
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
Système
Persisted until death
Non
Non
Mort
Treatment / Traitement
(p.ex. description des symptômes tels que la fréquence et la gravité
On 7-Feb-2020 the animal owner applied the product to their cat. Excessive collar material was not trimmed off. This was the first time the product had been used. The animal owner woke up on 10-Feb-2020 and found the cat dead. The cat has been buried. No further information is available.
Mort
Assessment: This product is considered to have a wide margin of safety in cats. The collar was not applied according to the label as the extra amount of collar material was not removed. If the extra collar was chewed on or ingested, GI upset such as vomiting or diarrhea could have occurred. Acute onset of death is not expected and other causes such as cardiac disease, respiratory disease, trauma, and toxin exposure should be considered. Necropsy may have provided additional information but was not sought by the animal owner. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.